This paper is in the following e-collection/theme issue:

Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1553) New Methods (902) Innovations and Technology in Cancer Care (400)

Published on in Vol 22, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19694, first published .
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Authors of this article:

François-Emery Cotté1 Author Orcid Image ;   Paméla Voillot2 Author Orcid Image ;   Bryan Bennett3 Author Orcid Image ;   Bruno Falissard4, 5, 6, 7 Author Orcid Image ;   Christophe Tzourio8, 9 Author Orcid Image ;   Pierre Foulquié2 Author Orcid Image ;   Anne-Françoise Gaudin1 Author Orcid Image ;   Hervé Lemasson1 Author Orcid Image ;   Valentine Grumberg10 Author Orcid Image ;   Laura McDonald11 Author Orcid Image ;   Carole Faviez2 Author Orcid Image ;   Stéphane Schück2 Author Orcid Image
Article Authors Cited by (9) Tweetations (23) Metrics

François-Emery Cotté   1 , PharmD, PhD, MPH ;   Paméla Voillot   2 , MSc ;   Bryan Bennett   3 , PhD ;   Bruno Falissard   4, 5, 6, 7 , MD, PhD ;   Christophe Tzourio   8, 9 , MD, PhD ;   Pierre Foulquié   2 , MSc ;   Anne-Françoise Gaudin   1 , PharmD ;   Hervé Lemasson   1 , MSc ;   Valentine Grumberg   10 , MSc ;   Laura McDonald   11 , PhD ;   Carole Faviez   2 , MSc ;   Stéphane Schück   2 , MD

1 Bristol-Myers Squibb, Rueil-Malmaison, France

2 Kap Code, Paris, France

3 Bristol-Myers Squibb, Stockport, United Kingdom

4 Paris-Sud University, Paris, France

5 Paris-Descartes Universitiy, Paris, France

6 AP-HP, Paris, France

7 INSERM U1178, Paris, France

8 Bordeaux University, Bordeaux, France

9 Inserm U1219, Bordeaux, France

10 UFR Pharmacy, Grenoble Alpes University, Grenoble, France

11 Bristol-Myers Squibb, London, United Kingdom

Corresponding Author: